Quanterix Q1 Revenue Up 20%, Reaffirms 2026 Guidance, Eyes H2 Cash Flow Breakeven
QTRX is trading near its 52-week low of $2.95 (14% above the low).
Summary
Quanterix Corporation reported a 20% year-over-year increase in Q1 revenue to $36.4 million and narrowed its adjusted EBITDA loss, signaling operational improvements. The company reaffirmed its 2026 revenue guidance of $169 million to $174 million. Critically, Quanterix expects to achieve cash flow breakeven in the second half of 2026 and projects ending the year with $100 million in cash and no debt. This positive financial outlook, particularly the path to cash flow breakeven, is a significant development for the company, especially following its last 10-K which reported an increased net loss and goodwill impairment. Traders will be watching for continued execution towards these financial targets.
At the time of this announcement, QTRX was trading at $3.35 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $154.4M. The 52-week trading range was $2.95 to $8.77. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.